One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice

This publication has 29 references indexed in Scilit:

• AAV-directed muscular dystrophy gene therapy
  Expert Opinion on Biological Therapy, 2010
• Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
  Gene Therapy, 2009
• Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
  The Lancet Neurology, 2009
• Octa-guanidine Morpholino Restores Dystrophin Expression in Cardiac and Skeletal Muscles and Ameliorates Pathology in Dystrophic mdx Mice
  Molecular Therapy, 2009
• Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs
  Annals of Neurology, 2009
• Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
  Proceedings of the National Academy of Sciences, 2008
• Emergent Dilated Cardiomyopathy Caused by Targeted Repair of Dystrophic Skeletal Muscle
  Molecular Therapy, 2008
• Prevention of Dystrophin-Deficient Cardiomyopathy in Twenty-One-Month-Old Carrier Mice by Mosaic Dystrophin Expression or Complementary Dystrophin/Utrophin Expression
  Circulation Research, 2008
• Current treatment of adult Duchenne muscular dystrophy
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
• Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
  Nature Medicine, 2006